2020
DOI: 10.1002/1873-3468.13737
|View full text |Cite
|
Sign up to set email alerts
|

Phosphatidylethanolamine accelerates aggregation of the amyloidogenic N‐terminal fragment of apoA‐I

Abstract: Membrane lipid composition is known to influence aggregation and fibril formation of many amyloidogenic proteins. Here, we found that phosphatidylethanolamine (PE) accelerates aggregation of the N-terminal 1-83 fragment of an amyloidogenic G26R variant of apoA-I on lipid membranes. Circular dichroism and isothermal titration calorimetry measurements demonstrated that PE does not affect the α-helical structure and lipid binding property of apoA-I 1-83/G26R. Rather, fluorescence measurements indicated that PE in… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 62 publications
0
1
0
Order By: Relevance
“…HDL particles typically have a discoidal shape with a diameter of 7–13 nm [ 10 ] and are built up by a patch of a lipid bilayer with the lipid acyl chains at the edges shielded from water by a circumference belt of α-helical ApoA-I [ 11 , 12 ]. While the exact molecular triggers of the conversion from healthy lipid-protein co-aggregates, HDL particles, to pathological aggregates, plaques, is not yet understood, lipid oxidation and the concentration of lipids, including cholesterol, seems to play a role [ 13 , 14 , 15 , 16 ]. Other identified factors are mutations and truncations of the ApoA-I sequence.…”
Section: Introductionmentioning
confidence: 99%
“…HDL particles typically have a discoidal shape with a diameter of 7–13 nm [ 10 ] and are built up by a patch of a lipid bilayer with the lipid acyl chains at the edges shielded from water by a circumference belt of α-helical ApoA-I [ 11 , 12 ]. While the exact molecular triggers of the conversion from healthy lipid-protein co-aggregates, HDL particles, to pathological aggregates, plaques, is not yet understood, lipid oxidation and the concentration of lipids, including cholesterol, seems to play a role [ 13 , 14 , 15 , 16 ]. Other identified factors are mutations and truncations of the ApoA-I sequence.…”
Section: Introductionmentioning
confidence: 99%